{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T03:02:17Z","timestamp":1788404537302,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010609","name":"Gda\u0144ski Uniwersytet Medyczny","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010609","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Environmental Sciences"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jes.2025.06.006","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T02:44:50Z","timestamp":1749177890000},"page":"88-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Drug interactions with perfluorooctanoic acid and perfluorooctane sulfonate in cytotoxic activity against prostate cancer - in vitro studies"],"prefix":"10.1016","volume":"159","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9255-3283","authenticated-orcid":false,"given":"Gra\u017cyna","family":"Ga\u0142\u0119zowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5556-3658","authenticated-orcid":false,"given":"Justyna","family":"Rogowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u0119drzej","family":"Antosiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jes.2025.06.006_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-022-02293-6","article-title":"Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response","volume":"41","author":"Ashrafizadeh","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.jes.2025.06.006_bib0002","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1158\/1535-7163.MCT-14-0265","article-title":"Antiproliferative mechanism of action of the novel taxane cabazitaxel as compared with the parent compound docetaxel in MCF7 breast cancer cells","volume":"13","author":"Azarenko","year":"2014","journal-title":"Mol. Cancer Ther."},{"issue":"21","key":"10.1016\/j.jes.2025.06.006_bib0003","doi-asserted-by":"crossref","first-page":"8020","DOI":"10.3390\/ijerph17218020","article-title":"PFAS environmental pollution and antioxidant responses: an overview of the impact on human field","volume":"17","author":"Bonato","year":"2020","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"1","key":"10.1016\/j.jes.2025.06.006_bib0004","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/pros.23446","article-title":"Estrogen receptor signaling in prostate cancer: implications for carcinogenesis and tumor progression","volume":"78","author":"Bonkhoff","year":"2018","journal-title":"Prostate"},{"issue":"14","key":"10.1016\/j.jes.2025.06.006_bib0005","doi-asserted-by":"crossref","first-page":"7900","DOI":"10.3390\/ijms23147900","article-title":"Low doses of PFOA promote prostate and breast cancer cells growth through different pathways","volume":"23","author":"Charazac","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jes.2025.06.006_bib0006","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.tice.2018.11.001","article-title":"Structural and molecular analysis of the cancer prostate cell line PC3: oocyte zona pellucida glycoproteins","volume":"55","author":"Costa","year":"2018","journal-title":"Tissue Cell"},{"issue":"8","key":"10.1016\/j.jes.2025.06.006_bib0007","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1289\/ehp.1510391","article-title":"Modeled perfluorooctanoic acid (PFOA) exposure and liver function in a mid-Ohio valley community","volume":"124","author":"Darrow","year":"2016","journal-title":"Environ. Health Perspect."},{"issue":"2","key":"10.1016\/j.jes.2025.06.006_bib0008","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41391-018-0081-6","article-title":"Estrogens and prostate cancer","volume":"22","author":"Dobbs","year":"2019","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"8","key":"10.1016\/j.jes.2025.06.006_bib0009","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/jnci\/djp041","article-title":"Perfluorooctanoate and perfluorooctanesulfonate plasma levels and risk of cancer in the general Danish population","volume":"101","author":"Eriksen","year":"2009","journal-title":"J. Nat. Cancer Inst."},{"issue":"5","key":"10.1016\/j.jes.2025.06.006_bib0010","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1289\/ehp.1104436","article-title":"Serum perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS) concentrations and liver function biomarkers in a population with elevated PFOA exposure","volume":"120","author":"Gallo","year":"2012","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.jes.2025.06.006_bib0011","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1097\/00043764-199309000-00020","article-title":"Mortality among employees of a perfluorooctanoic acid production plant","author":"Gilliland","year":"1993","journal-title":"J. Occup. Med."},{"issue":"C","key":"10.1016\/j.jes.2025.06.006_bib0012","first-page":"C1","article-title":"Skuteczna kontrola objaw\u00f3w zaawansowanego raka gruczo\u0142u krokowego\u2014Opis pacjenta leczonego octanem abirateronu","volume":"11","author":"G\u0142ogowski","year":"2015","journal-title":"Onkol. Prakt. Klin."},{"key":"10.1016\/j.jes.2025.06.006_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemosphere.2022.133873","article-title":"Concentrations of per-and polyfluoroalkyl substances (PFAS) in human placental tissues and associations with birth outcomes","volume":"295","author":"Hall","year":"2022","journal-title":"Chemosphere"},{"key":"10.1016\/j.jes.2025.06.006_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114902","article-title":"Per-and polyfluoroalkyl substances target and alter human prostate stem-progenitor cells","volume":"197","author":"Hu","year":"2022","journal-title":"Biochem. Pharmacol."},{"issue":"11","key":"10.1016\/j.jes.2025.06.006_bib0015","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.3390\/nu13113902","article-title":"Per- and polyfluoroalkyl substance exposure combined with high-fat diet supports prostate cancer progression","volume":"13","author":"Imir","year":"2021","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.jes.2025.06.006_bib0016","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/pros.22583","article-title":"Functional p53 determines docetaxel sensitivity in prostate cancer cells","volume":"73","author":"Liu","year":"2013","journal-title":"Prostate"},{"key":"10.1016\/j.jes.2025.06.006_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2023.114980","article-title":"Perfluoroalkyl substances promote breast cancer progression via ER\u03b1 and GPER mediated PI3K\/Akt and MAPK\/Erk signaling pathways","volume":"258","author":"Liu","year":"2023","journal-title":"Ecotoxicol. Environ. Saf."},{"issue":"22","key":"10.1016\/j.jes.2025.06.006_bib0018","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.24609","article-title":"Establishment and characterization of two cabazitaxel-resistant prostate cancer cell lines","volume":"9","author":"Machioka","year":"2018","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.jes.2025.06.006_bib0019","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.celrep.2015.02.063","article-title":"Prostate tumorigenesis induced by PTEN deletion involves estrogen receptor \u03b2 repression","volume":"10","author":"Mak","year":"2015","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.jes.2025.06.006_bib0020","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1289\/ehp.0901584","article-title":"Association between serum perfluorooctanoic acid (PFOA) and thyroid disease in the US National Health and Nutrition Examination Survey","volume":"118","author":"Melzer","year":"2010","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.jes.2025.06.006_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2020.114182","article-title":"Combined effects and toxicological interactions of perfluoroalkyl and polyfluoroalkyl substances mixtures in human liver cells (HepG2)","volume":"263","author":"Ojo","year":"2020","journal-title":"Environ. Pollut."},{"issue":"3","key":"10.1016\/j.jes.2025.06.006_bib0022","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3390\/ijerph16030342","article-title":"The waiting time of prostate cancer patients in Poland","volume":"16","author":"Osowiecka","year":"2019","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"2","key":"10.1016\/j.jes.2025.06.006_bib0023","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.cegh.2019.12.014","article-title":"Cancer incidence and mortality in Poland","volume":"8","author":"Religioni","year":"2020","journal-title":"Clin. Epidemiol. Glob. Health"},{"key":"10.1016\/j.jes.2025.06.006_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2023.107857","article-title":"Role of bioavailability and protein binding of four anionic perfluoroalkyl substances in cell-based bioassays for quantitative in vitro to in vivo extrapolations","volume":"173","author":"Qin","year":"2023","journal-title":"Environ. Int."},{"issue":"13","key":"10.1016\/j.jes.2025.06.006_bib0025","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.1021\/acs.est.3c09950","article-title":"Baseline toxicity model to identify the specific and nonspecific effects of per- and polyfluoroalkyl substances in cell-based bioassays","volume":"58","author":"Qin","year":"2024","journal-title":"Environ. Sci. Technol."},{"issue":"9","key":"10.1016\/j.jes.2025.06.006_bib0026","article-title":"Risk to human health related to the presence of perfluoroalkyl substances in food","volume":"18","author":"Schrenk","year":"2020","journal-title":"EFSA J."},{"key":"10.1016\/j.jes.2025.06.006_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2022.153281","article-title":"Comparative cytotoxicity of seven per-and polyfluoroalkyl substances (PFAS) in six human cell lines","volume":"477","author":"Solan","year":"2022","journal-title":"Toxicology"},{"key":"10.1016\/j.jes.2025.06.006_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2020.110690","article-title":"PFAS and cancer, a scoping review of the epidemiologic evidence","volume":"194","author":"Steenland","year":"2021","journal-title":"Environ. Res."},{"issue":"8","key":"10.1016\/j.jes.2025.06.006_bib0029","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1289\/ehp.0901827","article-title":"Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA)","volume":"118","author":"Steenland","year":"2013","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.jes.2025.06.006_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2022.128243","article-title":"In Vitro characterization of the endocrine disrupting effects of per-and poly-fluoroalkyl substances (PFASs) on the human androgen receptor","volume":"429","author":"Tachachartvanich","year":"2022","journal-title":"J. Hazard. Mat."},{"key":"10.1016\/j.jes.2025.06.006_bib0032","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3389\/fonc.2018.00400","article-title":"An ex vivo tissue culture model for the assessment of individualized drug responses in prostate and bladder cancer","volume":"8","author":"Van de Merbel","year":"2018","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.jes.2025.06.006_bib0031","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1210\/er.2011-1050","article-title":"Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses","volume":"33","author":"Vandenberg","year":"2012","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jes.2025.06.006_bib0033","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.envpol.2017.04.086","article-title":"Serum metabolome biomarkers associate low-level environmental perfluorinated compound exposure with oxidative\/nitrosative stress in humans","volume":"229","author":"Wang","year":"2017","journal-title":"Environ. Pollut."},{"key":"10.1016\/j.jes.2025.06.006_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2022.107219","article-title":"Per-and polyfluoralkyl substances (PFAS) in drinking water system: target and non-target screening and removal assessment","volume":"163","author":"Wang","year":"2022","journal-title":"Environ. Int."},{"issue":"1","key":"10.1016\/j.jes.2025.06.006_bib0035","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.tips.2016.10.006","article-title":"Estrogen receptor \u03b2 as a pharmaceutical target","volume":"38","author":"Warner","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.jes.2025.06.006_bib0036","first-page":"1558","article-title":"Perfluorooctanoic acid induces migration and invasion and inhibits apoptosis through the PI3K\/AKT signaling pathway in human rhabdomyosarcoma cells","volume":"42","author":"Zhang","year":"2019","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.jes.2025.06.006_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2024.176158","article-title":"Per-and polyfluoroalkyl substances (PFAS) and cancer: detection methodologies, epidemiological insights, potential carcinogenic mechanisms, and future perspectives","volume":"953","author":"Zheng","year":"2024","journal-title":"Sc. Total Environ."}],"container-title":["Journal of Environmental Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1001074225003547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1001074225003547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T13:45:46Z","timestamp":1762350346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1001074225003547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":37,"alternative-id":["S1001074225003547"],"URL":"https:\/\/doi.org\/10.1016\/j.jes.2025.06.006","relation":{},"ISSN":["1001-0742"],"issn-type":[{"value":"1001-0742","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug interactions with perfluorooctanoic acid and perfluorooctane sulfonate in cytotoxic activity against prostate cancer - in vitro studies","name":"articletitle","label":"Article Title"},{"value":"Journal of Environmental Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jes.2025.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}